Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset (original) (raw)
Ambrosino E et al. (2007) Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J Immunol 179:5126–5136 ArticleCASPubMed Google Scholar
Arora P et al. (2014) A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens. Immunity 40:105–116 ArticleCASPubMedPubMed Central Google Scholar
Arrenberg P, Halder R, Dai Y, Maricic I, Kumar V (2010) Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid. Proc Natl Acad Sci U S A 107:10984–10989 ArticleCASPubMedPubMed Central Google Scholar
Arrenberg P, Maricic I, Kumar V (2011) Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology 140:646–655 ArticleCASPubMed Google Scholar
Bai L et al. (2012) The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vdelta1 TCR. Eur J Immunol 42:2505–2510 ArticleCASPubMedPubMed Central Google Scholar
Bandyopadhyay K, Marrero I, Kumar V (2016) NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol 13:1–10 ArticleCAS Google Scholar
Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D (2002) Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16:583–594 ArticleCASPubMed Google Scholar
Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V, Batista FD (2010) CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol 11:303–312 ArticleCASPubMedPubMed Central Google Scholar
Behar SM, Podrebarac TA, Roy CJ, Wang CR, Brenner MB (1999) Diverse TCRs recognize murine CD1. J Immunol 162:161–167 CASPubMed Google Scholar
Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A (2000) In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 191:1895–1903 ArticleCASPubMedPubMed Central Google Scholar
Berntman E, Rolf J, Johansson C, Anderson P, Cardell SL (2005) The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol 35:2100–2109 ArticleCASPubMed Google Scholar
Blomqvist M et al. (2009) Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur J Immunol 39:1726–1735 ArticleCASPubMedPubMed Central Google Scholar
Brennan PJ, Brigl M, Brenner MB (2013) Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13:101–117 ArticleCASPubMed Google Scholar
Brennan PJ et al. (2011) Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 12:1202–1211 ArticleCASPubMedPubMed Central Google Scholar
Brigl M et al. (2011) Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med 208:1163–1177 ArticleCASPubMedPubMed Central Google Scholar
Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D (1995) CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J Exp Med 182:993–1004 ArticleCASPubMed Google Scholar
Chang DH et al. (2008a) Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood 112:1308–1316 ArticleCASPubMedPubMed Central Google Scholar
Chang WS et al. (2008b) Cutting edge: programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy. J Immunol 181:6707–6710 ArticleCASPubMed Google Scholar
Chiu YH, Jayawardena J, Weiss A, Lee D, Park SH, Dautry-Varsat A, Bendelac A (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 189:103–110 ArticleCASPubMedPubMed Central Google Scholar
Chiu YH et al. (2002) Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol 3:55–60. doi:10.1038/ni740 ArticleCASPubMed Google Scholar
Duarte N, Stenstrom M, Campino S, Bergman ML, Lundholm M, Holmberg D, Cardell SL (2004) Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted non classical NKT cells. J Immunol 173:3112–3118 ArticleCASPubMed Google Scholar
Durante-Mangoni E et al. (2004) Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J Immunol 173:2159–2166 ArticleCASPubMed Google Scholar
Duthie MS, Kahn M, White M, Kapur RP, Kahn SJ (2005) Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect Immun 73:181–192 ArticleCASPubMedPubMed Central Google Scholar
Exley MA, He Q, Cheng O, Wang RJ, Cheney CP, Balk SP, Koziel MJ (2002) Cutting edge: compartmentalization of Th1-like non invariant CD1d-reactive T cells in hepatitis C virus-infected liver. J Immunol 168:1519–1523 ArticleCASPubMed Google Scholar
Exley MA et al. (2001) CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 69:713–718 CASPubMed Google Scholar
Fais F et al. (2004) CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes. Int J Cancer 109:402–411 ArticleCASPubMed Google Scholar
Faveeuw C et al. (2002) Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J Immunol 169:906–912 ArticleCASPubMed Google Scholar
Girardi E, Zajonc DM (2012) Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells. Immunol Rev 250:167–179 ArticlePubMedPubMed CentralCAS Google Scholar
Girardi E, Maricic I, Wang J, Mac TT, Iyer P, Kumar V, Zajonc DM (2012) Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Nat Immunol 13:851–856 ArticleCASPubMedPubMed Central Google Scholar
Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB (2015) The burgeoning family of unconventional T cells. Nat Immunol 16:1114–1123 ArticleCASPubMed Google Scholar
Grishina ZV, Viryasova GM, Romanova YM, Sud’ina GF (2015) Polymorphonuclear leukocyte apoptosis is accelerated by sulfatides or sulfatides-treated Salmonella typhimurium bacteria. Biomed Res Int 2015:381232 ArticlePubMedPubMed CentralCAS Google Scholar
Gumperz JE, Miyake S, Yamamura T, Brenner MB (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195:625–636 ArticleCASPubMedPubMed Central Google Scholar
Halder RC, Aguilera C, Maricic I, Kumar V (2007) Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 117:2302–2312 ArticleCASPubMedPubMed Central Google Scholar
Hams E, Locksley RM, McKenzie AN, Fallon PG (2013) Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J Immunol 191:5349–5353 ArticleCASPubMed Google Scholar
Hashimoto M et al. (2011) SOCS1 regulates type I/type II NKT cell balance by regulating IFNgamma signaling. Int Immunol 23:165–176 ArticleCASPubMed Google Scholar
Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V (2004) Prevention of autoimmunity by targeting a distinct, non invariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 199:947–957 ArticleCASPubMedPubMed Central Google Scholar
Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A (2001) CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15:897–908 ArticleCASPubMed Google Scholar
Kadri N et al. (2012) CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. J Immunol 188:3138–3149 ArticleCASPubMed Google Scholar
Kain L et al. (2014) The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 41:543–554 ArticleCASPubMedPubMed Central Google Scholar
Kanamori M, Tasumi Y, Iyoda T, Ushida M, Inaba K (2012) Sulfatide inhibits alpha-galactosylceramide presentation by dendritic cells. Int Immunol 24:129–136 ArticleCASPubMed Google Scholar
Kawano T et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278:1626–1629 ArticleCASPubMed Google Scholar
Kim EY, Lynch L, Brennan PJ, Cohen NR, Brenner MB (2015) The transcriptional programs of iNKT cells. Semin Immunol 27:26–32 ArticleCASPubMed Google Scholar
Kim JH, Choi EY, Chung DH (2007) Donor bone marrow type II (non-valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4. J Immunol 179:6579–6587 ArticleCASPubMed Google Scholar
Kinjo Y, Kitano N, Kronenberg M (2013) The role of invariant natural killer T cells in microbial immunity. J Infect Chemother 19:560–570 ArticleCASPubMed Google Scholar
Kinjo Y et al. (2011) Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 12:966–974 ArticleCASPubMedPubMed Central Google Scholar
Knowlden S, Georas SN (2014) The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation. J Immunol 192:851–857 ArticleCASPubMedPubMed Central Google Scholar
Ko SY et al. (2007) Mediastinal lymph node CD8alpha-DC initiate antigen presentation following intranasal coadministration of alpha-GalCer. Eur J Immunol 37:2127–2137 ArticleCASPubMed Google Scholar
Kumar V, Delovitch TL (2014) Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology 142:321–336 ArticleCASPubMedPubMed Central Google Scholar
Kwiecinski J, Rhost S, Lofbom L, Blomqvist M, Mansson JE, Cardell SL, Jin T (2013) Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway. Infect Immun 81:1114–1120 ArticleCASPubMedPubMed Central Google Scholar
Lang GA, Devera TS, Lang ML (2008) Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood 111:2158–2162 ArticleCASPubMedPubMed Central Google Scholar
Liao CM, Zimmer MI, Shanmuganad S, Yu HT, Cardell SL, Wang CR (2012) Dysregulation of CD1d-restricted type ii natural killer T cells leads to spontaneous development of colitis in mice. Gastroenterology 142:326–334 e321-322 ArticleCASPubMed Google Scholar
Luoma AM et al. (2013) Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T cells. Immunity 39:1032–1042 ArticleCASPubMed Google Scholar
Macho-Fernandez E, Brigl M (2015) The extended family of CD1d-restricted NKT cells: sifting through a mixed bag of TCRs, antigens, and functions. Front Immunol 6:362 ArticlePubMedPubMed CentralCAS Google Scholar
Magalhaes K et al. (2010) Schistosomal-derived lysophosphatidylcholine are involved in eosinophil activation and recruitment through toll-like receptor-2-dependent mechanisms. J Infect Dis 202:1369–1379 ArticleCASPubMed Google Scholar
Mallevaey T et al. (2007) Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect Immun 75:2171–2180 ArticleCASPubMedPubMed Central Google Scholar
Maricic I, Girardi E, Zajonc DM, Kumar V (2014a) Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease. J Immunol 193:4580–4589 ArticleCASPubMedPubMed Central Google Scholar
Maricic I, Halder R, Bischof F, Kumar V (2014b) Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis. J Immunol 193:1035–1046 ArticleCASPubMedPubMed Central Google Scholar
Maricic I et al. (2015) Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology 61:1357–1369 ArticleCASPubMedPubMed Central Google Scholar
Marrero I, Ware R, Kumar V (2015) Type II NKT cells in inflammation, autoimmunity, microbial immunity, and cancer. Front Immunol 6:316 ArticlePubMedPubMed CentralCAS Google Scholar
Matsuda JL et al. (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192:741–754 ArticleCASPubMedPubMed Central Google Scholar
Parekh VV et al. (2009) PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. J Immunol 182:2816–2826 ArticleCASPubMedPubMed Central Google Scholar
Patel O et al. (2012) Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. Nat Immunol 13:857–863 ArticleCASPubMed Google Scholar
Pei B, Speak AO, Shepherd D, Butters T, Cerundolo V, Platt FM, Kronenberg M (2011) Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids. J Immunol 186:1348–1360 ArticleCASPubMed Google Scholar
Raghuraman G, Geng Y, Wang CR (2006) IFN-beta-mediated up-regulation of CD1d in bacteria-infected APCs. J Immunol 177:7841–7848 ArticleCASPubMed Google Scholar
Rakhshandehroo M et al. (2014) CD1d-mediated presentation of endogenous lipid antigens by adipocytes requires microsomal triglyceride transfer protein. J Biol Chem 289:22128–22139 ArticleCASPubMedPubMed Central Google Scholar
Renukaradhya GJ, Khan MA, Vieira M, Du W, Gervay-Hague J, Brutkiewicz RR (2008) Type I NKT cells protect (and type II NKT cells suppress) the host’s innate antitumor immune response to a B-cell lymphoma. Blood 111:5637–5645 ArticleCASPubMedPubMed Central Google Scholar
Rhost S, Lofbom L, Mansson J, Lehuen A, Blomqvist M, Cardell SL (2014) Administration of sulfatide to ameliorate type I diabetes in non-obese diabetic mice. Scand J Immunol 79:260–266 ArticleCASPubMed Google Scholar
Rhost S et al. (2012) Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte. Eur J Immunol 42:2851–2860 ArticleCASPubMed Google Scholar
Rolf J et al. (2008) Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets. Mol Immunol 45:2607–2620 ArticleCASPubMed Google Scholar
Ronger-Savle S et al. (2005) TGFbeta inhibits CD1d expression on dendritic cells. J Invest Dermatol 124:116–118 ArticleCASPubMed Google Scholar
Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI (2012) Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 12:845–857 ArticleCASPubMedPubMed Central Google Scholar
Roy KC, Maricic I, Khurana A, Smith TR, Halder RC, Kumar V (2008) Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells. J Immunol 180:2942–2950 ArticleCASPubMed Google Scholar
Schrumpf E et al. (2015) The biliary epithelium presents antigens to and activates natural killer T cells. Hepatology 62:1249–1259 ArticleCASPubMed Google Scholar
Schumann J, Pittoni P, Tonti E, Macdonald HR, Dellabona P, Casorati G (2005) Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells. J Immunol 175:7303–7310 ArticlePubMed Google Scholar
Sevastou I, Kaffe E, Mouratis MA, Aidinis V (2013) Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. Biochim Biophys Acta 1831:42–60 ArticleCASPubMed Google Scholar
Shah HB, Devera TS, Rampuria P, Lang GA, Lang ML (2012) Type II NKT cells facilitate alum-sensing and humoral immunity. J Leukoc Biol 92:883–893 ArticleCASPubMedPubMed Central Google Scholar
Shamshiev A, Gober HJ, Donda A, Mazorra Z, Mori L, De Libero G (2002) Presentation of the same glycolipid by different CD1 molecules. J Exp Med 195:1013–1021 ArticleCASPubMedPubMed Central Google Scholar
Shin JH, Park JY, Shin YH, Lee H, Park YK, Jung S, Park SH (2012) Mutation of a positively charged cytoplasmic motif within CD1d results in multiple defects in antigen presentation to NKT cells. J Immunol 188:2235–2243 ArticleCASPubMed Google Scholar
Sonoda KH, Stein-Streilein J (2002) CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol 32:848–857 ArticleCASPubMed Google Scholar
Subramanian L et al. (2012) NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]. PLoS One 7:e37771 ArticleCASPubMedPubMed Central Google Scholar
Sundell IB, Halder R, Zhang M, Maricic I, Koka PS, Kumar V (2010) Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis. J Stem Cells 5:33–42 PubMed Google Scholar
Tatituri RV et al. (2013) Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Proc Natl Acad Sci U S A 110:1827–1832 ArticleCASPubMedPubMed Central Google Scholar
Terabe M et al. (2005) A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 202:1627–1633 ArticleCASPubMedPubMed Central Google Scholar
Ushida M, Iyoda T, Kanamori M, Watarai H, Takahara K, Inaba K (2015) In vivo and in vitro analyses of alpha-galactosylceramide uptake by conventional dendritic cell subsets using its fluorescence-labeled derivative. Immunol Lett 168:300–305 ArticleCASPubMed Google Scholar
Wolf BJ et al. (2015) Identification of a potent microbial lipid antigen for diverse NKT cells. J Immunol 195:2540–2551 ArticleCASPubMed Google Scholar
Wu D et al. (2005) Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A 102:1351–1356 ArticleCASPubMedPubMed Central Google Scholar
Yang L, Jhaveri R, Huang J, Qi Y, Diehl AM (2007) Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers. Lab Investig 87:927–937 ArticleCASPubMed Google Scholar
Zajonc DM et al. (2005) Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med 202:1517–1526 ArticleCASPubMedPubMed Central Google Scholar
Zeissig S et al. (2012) Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 18:1060–1068 ArticleCASPubMedPubMed Central Google Scholar
Zeng D et al. (1998) Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J Exp Med 187:525–536 ArticleCASPubMedPubMed Central Google Scholar
Zhang G et al. (2011) Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma. Am J Phys Lung Cell Mol Phys 301:L975–L984 CAS Google Scholar
Zhao J, Weng X, Bagchi S, Wang CR (2014) Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response. Proc Natl Acad Sci U S A 111:2674–2679 ArticleCASPubMedPubMed Central Google Scholar
Zhou D et al. (2004a) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303:523–527 ArticleCASPubMed Google Scholar
Zhou D et al. (2004b) Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786–1789 ArticleCASPubMed Google Scholar